Canadian AIDS Treatment Information Exchange


CATIE's Vision
CATIE envisions a future free of HIV and hepatitis C.

CATIE's Mission
CATIE is Canada's source for accessible, evidence-based information about HIV and hepatitis C prevention, testing, care, treatment and support. CATIE strengthens the national response to HIV and hepatitis C by fostering collaboration and capacity among people living with HIV and/or hepatitis C and other affected populations, frontline service providers and researchers to reduce transmission and improve health and well-being.

Our Services
CATIE is Canada's source for up-to-date, unbiased information about HIV and hepatitis C. We connect people living with HIV or hepatitis C, at-risk communities, healthcare providers and community organizations with the knowledge, resources and expertise to reduce transmission and improve quality of life.

Connect With the Tools You Need
The latest news about HIV and hepatitis C treatment and prevention in clear language

  • Accurate online information
  • Research updates
  • Confidential inquiry line

Resources developed in partnership with organizations across Canada

  • Free publications
  • Program tools
  • Case studies

Events for service providers to share approaches and lessons learned

  • CATIE Forum
  • Regional conferences
  • Learning Institutes

Educational opportunities in person and online

  • Webinars
  • Workshops
  • Training courses

Order a CATIE Brochure
This bilingual brochure provides a brief overview of CATIE's programs and services. Order a copy from the CATIE Ordering Centre.

CATIE's History

Read more about CATIE's history and milestones.

How to Reach CATIE

CATIE (Canadian AIDS Treatment Information Exchange)
555 Richmond Street West, Suite 505
Box 1104
Toronto, Ontario M5V 3B1 Canada

Phone: 416.203.7122 or 1.800.263.1638
Fax: 416.203.8284

Categories Covered:Other Populations, Women, HIV Treatment and Medical Care, Nutrition and Fitness, People Over 50, HIV Epidemiology, Adverse Events, Comorbidities, and HIV, HIV and Mental Health Care, HIV Advocates in the Spotlight, Gay Men, Tenofovir Disoproxil Fumarate (Viread), Switching or Stopping HIV Treatment, Managing People Newly Diagnosed With HIV, HIV Care Continuum, HIV in the Arts, Providing Quality HIV Care, U=U (Undetectable Equals Untransmittable, i.e. HIV Treatment as Prevention), HIV Testing, Managing Primary/Acute HIV Infection, HIV Prevention Methods, Living Well With HIV, Lopinavir/Ritonavir (Kaletra), Raltegravir (Isentress), Kidney Issues and HIV, Non-HIV Sexually Transmitted Infections, HIV Treatment Strategies, PrEP (HIV Pre-Exposure Prophylaxis), HIV in Specific Countries, Mental Health, Newly Diagnosed, Relationships and Sex, HIV/AIDS Basics, HIV Education and Risk Management, Body Fat, Lipodystrophy and HIV, HIV, Discrimination, and Law, Finding HIV Support Groups and Services, HIV Treatments in Development, HIV Care and Services Outside the US, History of HIV/AIDS, Starting HIV Treatment and Medical Care, HIV in Film, TV, and Media, Latinx People, HIV Basic Science and Pathogenesis, Cobicistat/Emtricitabine/Elvitegravir/Tenofovir Alafenamide (Genvoya, E/C/F/TAF), Pregnancy, Childbirth, and HIV, Managing Long-Term HIV Survivors, PEP (HIV Post-Exposure Prophylaxis), Rilpivirine (Edurant), Efavirenz (Sustiva, Stocrin), Dental/Mouth Issues and HIV, Physical Health Issues, Dolutegravir (Tivicay), Substance Use and Harm Reduction for HIV, PrEP (HIV Pre-Exposure Prophylaxis), HIV Advocacy and Activism, HIV/AIDS Outside the U.S., HIV Stigma and Discrimination, Bone Problems and HIV, FDA-Approved HIV Medications, Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy, B/F/TAF), HIV Prevention and Transmission, Hormone-Related Issues and HIV, Darunavir (Prezista), People Under 30, HIV Prevention for People With HIV, HIV in Books and Publishing, Viramune (Nevirapine), First-Line HIV Treatment, Meeting the Costs of HIV Care, HIV/AIDS Statistics, Ritonavir (Norvir), Emtricitabine/Tenofovir Alafenamide (Descovy), Heart Disease and HIV, Maraviroc (Selzentry, Celsentri), Neuorlogical (Brain/Nerve) Issues and HIV, Conceiving and Having a Baby, Abacavir (Ziagen), Etravirine (Intelence), Tools and Tips for HIV Advocacy, Spirituality and Religion, HIV Case Management and Social Work, Disclosing Your HIV Status, Managing HIV Drug Resistance, Nevirapine (Viramune), Didanosine (ddI, Videx), Anemia, Fatigue, and HIV, Atazanavir (Reyataz), Enfuvirtide (T-20, Fuzeon), Personal Stories from the HIV Community, Gastrointestinal (Gut) Issues and HIV, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate (Stribild), Managing HIV Drug Resistance, Non-Medical HIV Prevention, Tuberculosis and HIV, Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada), Cobicistat (Tybost), Pediatric HIV Care, Understanding HIV-Related Lab Tests, African-Americans, Saquinavir (Invirase)

Latest by Canadian AIDS Treatment Information Exchange

Insufficient Food Linked to Inflammation in HIV-Positive Women

Women who experienced food insecurity were more likely to have elevated levels of inflammation. Researchers suspect that food insecurity causes stress, and this stress in turn raises inflammation in HIV-positive women.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange

Pilot Study Finds Intense Exercise Is Good for Older HIV-Positive Men

In a recent study, older men who engaged in high-intensity aerobic exercise (but not moderate intensity) showed a significantly increased their ability to maximize their use of oxygen.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange

AIDS 2018: The Good and the Bad

"At this year's International AIDS Conference ... we witnessed several pivotal developments in the global HIV response," Sean Hosein writes. "We also saw some setbacks in our efforts to prevent infections and improve the lives of people living with H...

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange

Lovin' With HIV

It's no secret that when it comes to sex, an HIV diagnosis has been known to throw a wrench in the works. Two women discuss how they navigate sexual satisfaction and HIV.

By Allison Carter for Canadian AIDS Treatment Information Exchange

U=U: The Backstory

What good is groundbreaking science if people don't know about it? Bruce Richman, the driving force behind U=U, describes how the once-unpopular campaign gained critical mass.

By Bruce Richman for Canadian AIDS Treatment Information Exchange

8 Questions About PrEP for Guys

Answers to common questions about pre-exposure prophylaxis (PrEP), including benefits, access, effectiveness, and more.

By Camille Arkell for Canadian AIDS Treatment Information Exchange

'U=U': What's It All About?

When a person taking antiretroviral treatment has an ongoing undetectable viral load and is engaged in care, they do not transmit HIV to their sexual partners. Here is why supporting "undetectable equals untransmittable" is important.

By Camille Arkell for Canadian AIDS Treatment Information Exchange

Love Positive Women: Why a Fulfilling Sexual Life With HIV Matters

Although most attention is paid to preventing the transmission of HIV to intimate partners, women's sexual concerns go far beyond condom use.

By Allison Carter, Angela Kaida and Jessica Whitbread for Canadian AIDS Treatment Information Exchange

U=U: The Evidence Is In

If you are HIV positive, take treatment and maintain an undetectable viral load, you can have sex knowing that you won't pass HIV to your sex partner.

By Canadian AIDS Treatment Information Exchange

Stigma Stings: 3 Women Who Face Stigma With Courage and Resilience

While treatment has advanced in leaps and bounds and HIV has become much more manageable, stigma remains rampant.

By Kath Webster for Canadian AIDS Treatment Information Exchange